Added to YB: 2025-01-07
Pitch date: 2024-09-30
MEDP [bullish]
Medpace Holdings, Inc.
+48.61%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
$12.8B
Pitch Price
$333.75
Price Target
N/A
Dividend
N/A
EV/EBITDA
20.52
P/E
29.53
EV/Sales
4.92
Sector
Life Sciences Tools and Services
Category
turnaround
Show full summary:
Wasatch Global Investors Small Cap Growth Strategy Portfolio Holding: Medpace Holdings, Inc.
MEDP: CRO for small biotech. Q3 missed on weak new biz wins due to biotech funding & cancellations. Stock down but long-term thesis intact. Expect growth as biotech innovation continues & more firms use Medpace for development services.
Read full article (1 min)